Login
$JAZZ
$207.83 +$2.77 (1.35%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Renee D. Gala Also a director
PRESIDENT, CEO AND DIRECTOR
54 Not stated Not stated $19,151,558
Philip L. Johnson
EXECUTIVE VICE PRESIDENT AND CFO
62 Since 2024
2 years
Not stated $7,544,473
Robert Iannone
EVP, Global Head of R&D & CMO
Title from the Form 4 dated Aug 27, 2026
59 Not stated Not stated Not reported
Neena M. Patil
EXECUTIVE VICE PRESIDENT AND CHIEF LEGAL OFFICER
51 Since 2022
4 years
2019 $6,299,539
Patricia Carr
SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
55 Not stated Not stated Not reported
Mary Elizabeth Henderson
SENIOR VICE PRESIDENT, TECHNICAL OPERATIONS
54 Since 2023
3 years
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
13
serving now
Independent
10 of 10
stated in the proxy; 3 not stated
Average tenure
9.5 years
from year joined
CEO also chairs the board
No
Bruce C. Cozadd
Director Age On board Independent Committees Other public boards 2025 pay Source
Bruce C. Cozadd
62 2003
23 years
Not stated None stated None stated Not stated
Renee D. Gala
54 2025
1 year
Not stated None stated Dexcom, Inc. Paid as CEO
Heather Ann McSharry
64 2013
13 years
Independent
Nominating Committee · Chair
International Airlines Group, S.A. $528,064
Rick E Winningham
66 2010
16 years
Independent
Nominating Committee
Theravance BioPharma, Inc. $555,564
Jennifer E. Cook
60 2020
6 years
Independent
Compensation Committee · Chair
BridgeBio Pharma, Inc. $520,564
Patrick G. Enright
64 2009
17 years
Independent
Audit Committee
BioAge Labs Inc $495,564
Laura J. Hamill
61 2024
2 years
Independent
Compensation Committee
BB Biotech AG $480,564
Patrick Kennedy
57 2024
2 years
Independent
Audit Committee · Chair
None stated $503,064
Ted W. Love, M.D.
67 2025
1 year
Independent
Audit Committee
Gilead Sciences, Inc. $8,542
Seamus C. Mulligan
65 2012
14 years
Independent
Transaction Committee · Chair
None stated $500,564
Norbert G. Riedel, Ph.D.
68 2013
13 years
Independent
SMC · Chair
Eton Pharmaceuticals, Inc. $518,064
Mark D. Smith, M.D.
74 2020
6 years
Independent
Nominating Committee
Phreesia, Inc. $490,564
Anne O’Riordan Leaving at the meeting
Not stated Not stated Not stated None stated None stated $495,564

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jun 8, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support